Skip to Main Content
HIV/AIDS, Phase COVID-NA

Mechanisms of HIV latency

What is the purpose of this trial?

participants will donate 150 ml of blood (around 5 ounces, less than 1/3 of a regular Red Cross blood donation) for each visit. Participants will be compensated. In some occasions, the study participants may be requested to donate for additional times, but no sooner than 8 weeks.

  • Trial with
    American Foundation for AIDS Research, Gilead Sciences, Yale University School of Medicine, University of Massachusetts, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), and University of Utah
  • Ages
    18 years and older
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Ya-Chi Ho

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    07/28/2024
  • Study HIC
    #2000021845REG